Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription 24.08.2026 1 Am J Pathol 2 Ann Oncol 1 Ann Thorac Surg 1 Br J Cancer 1 Cancer Lett 1 Clin Lung Cancer 2 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 1 J Surg Oncol 16 Lung Cancer 1 N Engl J Med 1 Oncogene 1 Oncol Rep 1 Oncologist 1 Proc Natl Acad Sci U S A 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. KONNO K, Sato-Yazawa H, Ishii J, Kashiwagi K, et al
   Dual Mechanisms Underlie the Repression of Repressor Element 1-Silencing Transcription Factor Expression in Lung Neuroendocrine Carcinoma Cells.
   Am J Pathol. 2026;196:1839-1854.
   PubMed         Abstract available
   
   

   
   Ann Oncol

2. WAKELEE H, Spicer JD, Gao S, Liberman M, et al
   Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
   Ann Oncol. 2026 Aug 21:S0923-7534(26)01462-6. doi: 10.1016/j.annonc.2026.
   PubMed         Abstract available
   
   
3. FACCHINETTI F, Friboulet L, Liao L, Peroni M, et al
   Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer.
   Ann Oncol. 2026 Aug 18:S0923-7534(26)01458-4. doi: 10.1016/j.annonc.2026.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

4. TSAI LL, Anokwuru C, Kapula N, Fan J, et al
   Lung Cancer Risk for Patients Undergoing Cardiac Chest CT: Identification of a New High Risk Population for Lung Cancer Screening.
   Ann Thorac Surg. 2026 Aug 18:S0003-4975(26)00829.
   PubMed         Abstract available
   
   

   
   Br J Cancer

5. HEKTOEN HH, Tsuruda KM, Maehlen MT, Helland A, et al
   Real-world outcomes of immunotherapy in advanced NSCLC patients with comorbidities.
   Br J Cancer. 2026;135:763-772.
   PubMed         Abstract available
   
   

   
   Cancer Lett

6. SUN Y, Zhen F, Wang H, Tian H, et al
   USP22 Enhances Mitochondrial Biogenesis via Stabilizing MYBBP1A in Non-Small Cell Lung Cancer.
   Cancer Lett. 2026 Aug 21:218789. doi: 10.1016/j.canlet.2026.218789.
   PubMed         Abstract available
   
   

   
   Clin Lung Cancer

7. REGNERY S, Ehle M, Neugebauer D, Gerke L, et al
   Spatially Fractionated Induction Radiotherapy to Widen the Therapeutic Window in Locally Advanced Non-Small-Cell Lung Cancer (SPARROW): Study Protocol of a Multicenter, Randomized, Open-Label Seamless Phase I/II Trial.
   Clin Lung Cancer. 2026;27:125-128.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

8. NGUYEN C, Chen J, Larner J, Colen J, et al
   Forecasting Time-Dependent Radiation Induced Lymphocyte Depletion in a Clinical Trial on Early-Stage Lung Cancer.
   Int J Radiat Oncol Biol Phys. 2026 Aug 18:S0360-3016(26)04190.
   PubMed         Abstract available
   
   
9. ZHANG YH, Iqbal A, Gelblum D, Ma J, et al
   A Phase I Study of Cyclical Hypofractionated Palliative Radiotherapy (Quad Shot) for Central Lung Tumors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC): Results from the PROMISE 006 Trial Thoracic Quad Shot RT in Stage IV NSCLC.
   Int J Radiat Oncol Biol Phys. 2026 Aug 18:S0360-3016(26)04202.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

10. WHEATLEY PRICE P, Ismaila N, Calles Blanco A, Cetnar J, et al
    Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.
    J Clin Oncol. 2026 Aug 17:101200JCO2601958. doi: 10.1200/JCO-26-01958.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

11. KELLY CJ, Ding L, Harano T, Atay SM, et al
    Determinants of Failure to Rescue After Pulmonary Resection for Lung Cancer: Insights From a National Inpatient Sample.
    J Surg Oncol. 2026 Aug 18. doi: 10.1002/jso.70376.
    PubMed         Abstract available
    
    

    
    Lung Cancer

12. ANOSIKE UG, Oliveira Amador WF, Cruz de Assis TC, Maciel RB, et al
    Outcomes of robotic vs video-assisted thoracoscopic segmentectomy in early-stage NSCLC: A meta-analysis of propensity-matched studies.
    Lung Cancer. 2026;219:109531.
    PubMed         Abstract available
    
    
13. PETRELLI F, Dottorini L, D'Alessio A, Tarantini F, et al
    Interstitial lung disease in patients treated with antibody-drug conjugates: a review.
    Lung Cancer. 2026;219:109532.
    PubMed         Abstract available
    
    
14. KAWAI H, Yatabe Y, Yoshizawa A, Sakai Y, et al
    AI analysis of elastin staining sections reveals the biological implications of cancer-related fibrosis in small-sized lung adenocarcinomas.
    Lung Cancer. 2026;219:109542.
    PubMed         Abstract available
    
    
15. XUE L, Feng Y, Chen P, Ye W, et al
    First-line treatment for unresectable pulmonary lymphoepithelial carcinoma: A real-world comparison of platinum-based doublet chemotherapy with or without PD-1 inhibitors.
    Lung Cancer. 2026;219:109543.
    PubMed         Abstract available
    
    
16. WU TY, Liu NT, Wu YC, Liu CH, et al
    A novel MYO5C-ALK fusion in lung adenocarcinoma: limited alectinib response and durable lorlatinib benefit.
    Lung Cancer. 2026;219:109548.
    PubMed         Abstract available
    
    
17. NOBERINI R, Bischinioti I, Zanetti S, Vai A, et al
    Epiproteomic profiling identifies histone H4 hyperacetylation as a prognostic marker in pleural mesothelioma.
    Lung Cancer. 2026;219:109544.
    PubMed         Abstract available
    
    
18. NISHIMURA T, Shimomura M, Okada S, Takeda-Miyata N, et al
    Prediction of spread through air spaces with biopsy specimens in early-stage adenocarcinoma of the lung.
    Lung Cancer. 2026;219:109546.
    PubMed         Abstract available
    
    
19. WU Y, Chen H, Wu Y, Zhao Q, et al
    Development and validation of a risk-stratification model for individualized management of leptomeningeal metastases in EGFR- mutant NSCLC (LM-Index).
    Lung Cancer. 2026;219:109547.
    PubMed         Abstract available
    
    
20. KIRMANN J, Riffet M, Bazille C, Quintyn ML, et al
    Clinicopathological and prognostic validation of pulmonary carcinoid/NET G3: evidence for a distinct subgroup of well-differentiated neuroendocrine neoplasms.
    Lung Cancer. 2026;219:109545.
    PubMed         Abstract available
    
    
21. TORCHIAT A, Silina K, Nair AA, Heeb LV, et al
    Low baseline cGAS expression is associated with longer progression-free survival in patients with pleural mesothelioma.
    Lung Cancer. 2026;219:109553.
    PubMed         Abstract available
    
    
22. GUO J, Qiu S, You H, Zhang H, et al
    DAFNet: A multi-modal deep learning model based on whole-lung CT for the automated prediction of the air space spread of lung adenocarcinoma.
    Lung Cancer. 2026;219:109557.
    PubMed         Abstract available
    
    
23. LOMBARDI M, Gerckens M, Alkan GH, Khmelovska D, et al
    Immune signatures in NSCLC associated pleural effusions and implications for prognosis.
    Lung Cancer. 2026;219:109563.
    PubMed         Abstract available
    
    
24. LIU Z, Zhu Y, Bi W, Han Z, et al
    Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling.
    Lung Cancer. 2026;220:109579.
    PubMed         Abstract available
    
    
25. ZHOU H, Zhou Q, Guo Q, Guo W, et al
    A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAF(V600E) mutated metastatic non-small cell lung cancer: Results from the OCEAN II study.
    Lung Cancer. 2026;220:109580.
    PubMed         Abstract available
    
    
26. GAN X, Yu Z, Zhang L, Xie W, et al
    Efficacy and prognostic analysis of induction chemoimmunotherapy in unresectable stage ? non-small cell lung cancer: a single-center retrospective study.
    Lung Cancer. 2026;220:109578.
    PubMed         Abstract available
    
    
27. GAO R, Li Z, Huang J, Zhao J, et al
    Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis.
    Lung Cancer. 2026;220:109566.
    PubMed         Abstract available
    
    

    
    N Engl J Med

28. ZHOU C, Greillier L, Liu G, John T, et al
    First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.
    N Engl J Med. 2026;395:765-775.
    PubMed         Abstract available
    
    

    
    Oncogene

29. LIN C, Liu J, Ni J, Chen D, et al
    Multiparatopic antibodies overcome tyrosine kinase inhibitor resistance by inducing lysosomal degradation of EGFR mutants.
    Oncogene. 2026;45:3511-3524.
    PubMed         Abstract available
    
    

    
    Oncol Rep

30. BAI X, Yang Y, Luo Y, Jing P, et al
    Combination of lonidamine with devimistat induces synergistic antitumor effects in lung cancer via multifaceted disruption of cellular energy metabolism.
    Oncol Rep. 2026;56:178.
    PubMed         Abstract available
    
    

    
    Oncologist

31. MOHINDROO C, Takahashi N, Nichols S, Pinkiert D, et al
    Phase II Study of Olaparib Plus Durvalumab in EGFR-Mutant NSCLC Transformed to Small Cell Lung Cancer.
    Oncologist. 2026 Aug 14:oyag328. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

32. BIRLA P, Yang L, Shan W, Minamisawa S, et al
    Select intratumoral riboflavin-auxotrophic Enterococcus species enhance cell surface MR1 expression and MAIT TCR activation in lung cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2617943123.
    PubMed         Abstract available
    
    

    
    Thorax

33. ATKINS KM, Zhang SC, Kehayias CE, Guthier C, et al
    Association of pulmonary artery radiation with pulmonary hypertension after lung cancer radiotherapy.
    Thorax. 2026 Aug 20:thorax-2025-224178. doi: 10.1136/thorax-2025-224178.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum